Cite
HARVARD Citation
Li, S. et al. (2021). A phase I clinical trial of human embryonic stem cell‐derived retinal pigment epithelial cells for early‐stage Stargardt macular degeneration: 5‐years' follow‐up. Cell proliferation. p. n/a. [Online].